glp-1 news today 2025 october 9 Weighty issue: drugs are reshaping packaging demand FDA issued 25 warning letters

Honest, physician-led care sets realistic expectations up front and reviews your actual response over time

According to the World Health Organization, in 2019, diabetes was the cause of 1.5 million deaths

The injectable supplement is used to manage many health conditions, such as heart and circulatory problems, and also to improve fitness and athletic performance

Bouayed J, Rammal H, Soulimani R

FDA guidance documents: The FDA may issue additional guidance that clarifies its expectations for GLP-1 compounding, provides transition periods for pharmacies to wind down operations after shortage resolutions, or establishes clearer standards for compounded peptide medications

For distinguishing diabetic nephropathy from non-diabetic kidney disease, it attained AUCs of 0.906 internally and 0.7330.844 externally in biopsy-confirmed cases